Abstract:BackgroundIn the United States, about 3 million people have autism spectrum disorder (ASD), and around 1 out of 59 children are diagnosed with ASD. People with ASD have characteristic social communication deficits and repetitive behaviors. The causes of this disorder remain unknown; however, in up to 25% of cases, a genetic cause can be identified. Detecting ASD as early as possible is desirable because early detection of ASD enables timely interventions in children with ASD. Identification of ASD based on objective pathogenic mutation screening is the major first step toward early intervention and effective treatment of affected children. ObjectiveRecent investigation interrogated genomics data for detecting and treating autism disorders, in addition to the conventional clinical interview as a diagnostic test. Since deep neural networks perform better than shallow machine learning models on complex and high-dimensional data, in this study, we sought to apply deep learning to genetic data obtained across thousands of simplex families at risk for ASD to identify contributory mutations and to create an advanced diagnostic classifier for autism screening. MethodsAfter preprocessing the genomics data from the Simons Simplex Collection, we extracted top ranking common variants that may be protective or pathogenic for autism based on a chi-square test. A convolutional neural network–based diagnostic classifier was then designed using the identified significant common variants to predict autism. The performance was then compared with shallow machine learning–based classifiers and randomly selected common variants. ResultsThe selected contributory common variants were significantly enriched in chromosome X while chromosome Y was also discriminatory in determining the identification of autistic individuals from nonautistic individuals. The ARSD, MAGEB16, and MXRA5 genes had the largest effect in the contributory variants. Thus, screening algorithms were adapted to include these common variants. The deep learning model yielded an area under the receiver operating characteristic curve of 0.955 and an accuracy of 88% for identifying autistic individuals from nonautistic individuals. Our classifier demonstrated a considerable improvement of ~13% in terms of classification accuracy compared to standard autism screening tools. ConclusionsCommon variants are informative for autism identification. Our findings also suggest that the deep learning process is a reliable method for distinguishing the diseased group from the control group based on the common variants of autism.

Prediction and prioritization of autism-associated long non-coding RNAs using gene expression and sequence features

Diagnostic Classification and Prognostic Prediction Using Common Genetic Variants in Autism Spectrum Disorder: Genotype-Based Deep Learning

Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders

A deep learning predictive classifier for autism screening and diagnosis

Brain-specific Functional Relationship Networks Inform Autism Spectrum Disorder Gene Prediction

Integrative analysis of long noncoding RNAs dysregulation and synapse-associated ceRNA regulatory axes in autism.

Exploiting Aberrant Mrna Expression in Autism for Gene Discovery and Diagnosis

Gene Screening for Autism Based on Cell-type-specific Predictive Models.

Network assisted analysis to reveal the genetic basis of autism

Forecasting risk gene discovery in autism with machine learning and genome-scale data

Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development

Artificial intelligence and bioinformatics analyze markers of children's transcriptional genome to predict autism spectrum disorder

DeepASDPred: a CNN-LSTM-based deep learning method for Autism spectrum disorders risk RNA identification

Cell type-specific predictive models for prioritizing genes and gene sets associated with autism spectrum disorder

Genome-wide prediction of dominant and recessive neurodevelopmental disorder risk genes

Integrated Analysis and Identification of Genetic Risk Alleles Related to Autism Spectrum Disorder

Why not try to predict autism spectrum disorder with crucial biomarkers in cuproptosis signaling pathway?

Machine Learning-Based Blood RNA Signature for Diagnosis of Autism Spectrum Disorder

Prioritizing Autism Risk Genes Using Personalized Graphical Models Estimated From Single-Cell RNA-seq Data

Single Nucleotide Polymorphisms Predict Symptom Severity of Autism Spectrum Disorder

Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected families